HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Cephaloridine

HCID 5773
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
50-59-9
Standard SMILES
O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12
InChIKey
CZTQZXZIADLWOZ-CRAIPNDOSA-N
Molecular formula
C19H17N3O4S2
Average molar mass
415.5 g/mol
Monoisotopic mass
415.06604838

Overview

Cefaloridine is a cephalosporin compound having pyridinium-1-ylmethyl and 2-thienylacetamido side-groups. A first-generation semisynthetic derivative of cephalosporin C. It has a role as an antibacterial drug. It is a cephalosporin, a semisynthetic derivative and a beta-lactam antibiotic allergen.

Names & identifiers

Preferred name
Cephaloridine
IUPAC
(6R,7R)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
English name
Cephaloridine
Molecular formula
C19H17N3O4S2
Molecular weight
415.48

Names & synonyms

cephaloridinecefaloridine50-59-9CephaloridinCephaloridinumCefaloridinCefalorizinCepaloridinCephalomycineLoridineCefaloridinaCeflorin
Show more names
SefacinCeporanKeflodinKeflordinSch 11527Cephaloridine IICephaloridine USP/EP/BP
CepalorinKefloridinCeporinCefaloridinumGlaxoridinAmpligramCeporineDeflorin

Database identifiers

CAS
50-59-9
PubChem CID
5773
DTXSID
DTXSID9022782
ChEMBL
CHEMBL316157
ChEBI
CHEBI:3537
UNII
LVZ1VC61HB
EC Number
200-052-6

Properties

Computed structural properties

XLogP
1.9
Topological polar surface area
147 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
6
Rotatable bonds
5
Heavy atoms
28
Formal charge
0
Complexity
687

Experimental & physicochemical properties

DrugsPharmaceuticals -> Antibiotics
pHAQ SOLN ARE SLIGHTLY ACID (PH 4.5-5)
LogPLogP = -1.70 at pH = 2
Color/Form · 2 items

CRYSTALS

WHITE TO OFF-WHITE, CRYSTALLINE POWDER

Solubility · 3 items

SOL IN WATER

PRACTICALLY INSOL IN MOST ORG SOLVENTS

In water, >2.0X10+4 at 21 °C

Flash PointNo data
Optical RotationSPECIFIC OPTICAL ROTATION: +47.7 °FOR D (SODIUM) LINE (WATER, 1.25%)
Stability/Shelf LifeAQ SOLN (20% WT/VOL) ARE STABLE FOR 4 WK @ 4 °C IN DARK
Other Experimental Properties · 2 items

EXPOSURE TO SUNLIGHT CAUSES DISCOLORATION

Aqueous solutions (20% w/v) are stable for four weeks at 4 °C in the dark.

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory InformationChemical: Pyridinium, 1-[[(6R,7R)-2-carboxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, inner salt
FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Special ReportsWHO; Environmental Health Criteria 119: Principles and Methods for the Assessment of Nephrotoxicity Associated with Exposure to Chemicals (1991)
Hazard Classes and CategoriesSkin Sens. 1 (100%)

Safety & protection

Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Chemistry & industry

Pharmacology

ATC Code · 2 items

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Mechanism of Action · 2 items

CEPHALOTHIN & ITS CONGENERS INHIBIT BACTERIAL CELL-WALL SYNTHESIS IN MANNER SIMILAR TO THAT OF PENICILLIN. /CEPHALOSPORINS/

Cephaloglycin and cephaloridine are acutely toxic to the proximal renal tubule, in part because of their cellular uptake by a contraluminal anionic secretory carrier and in part through their intracellular attack on the mitochondrial transport and oxidation of tricarboxylic acid (TCA) cycle anionic substrates. Preliminary studies with cephaloglycin have provided evidence of a role of fatty acid (FA) metabolism in its nephrotoxicity, and work with cephaloridine has shown it to be a potent inhibitor of renal tubular cell and mitochondrial carnitine (Carn) transport.

Biological Half-Life · 2 items

.../CEPHALORIDINE/ PEAK PLASMA CONCN ARE REACHED ABOUT 30 MIN AFTER DRUG IS INJECTED... WHILE ITS T/2 (60 TO 90 MIN)...ONLY SMALL AMT ARE DETECTABLE AFTER 8 HR.

/IN RATS/ RATIOS OF BONE TO SERUM CONCN AVG...1:7 FOR CEPHALORIDINE...DURING 0.25-4 HR AFTER /ORAL OR SC/ DOSING. DESPITE DIFFERENCES IN CONCN, T/2 IN BONE & SERUM WERE SIMILAR.

MeSH Pharmacological ClassificationSubstances that inhibit the growth or reproduction of BACTERIA.
Absorption, Distribution and Excretion · 6 items

Renal.

.../CEPHALORIDINE/ POORLY ABSORBED FROM GI TRACT. PEAK PLASMA CONCN ARE REACHED ABOUT 30 MIN AFTER DRUG IS INJECTED; 10 TO 20% OF PLASMA CEPHALORIDINE IS BOUND TO PROTEIN.

IM INJECTIONS OF 0.5 & 1 G YIELD PEAK PLASMA CONCN OF 15 & 30 UG/ML, RESPECTIVELY. APPROX 75% OF GIVEN DOSE IS EXCRETED IN URINE, MAINLY BY GLOMERULAR FILTRATION. CEPHALORIDINE ACCUM IN BLOOD OF PATIENTS WITH DECR RENAL FUNCTION, & IN AZOTEMIC PATIENTS PLASMA CONCN ARE VERY HIGH...

PLACENTAL DRUG TRANSFER- CEPHALORIDINE: TIME TO APPEAR IN FETUS 30 MIN; TIME TO FETAL/MATERNAL CONCN EQUIL 5 HR. /FROM TABLE/

.../CEPHALORIDINE/ READILY PENETRATE NORMAL EYE FOLLOWING SYSTEMIC OR SUBCONJUNCTIVAL ADMIN...

Related reactions

1 records
New reaction record
HRID 1604922 reaction equation
HRID 1604922As productuspto-grants-1976_04

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Physicochemical properties

Melting point
184 °C · 184°C
alpha
47.7 ° · D +47.7° (c = 1.25 in water)
Density
1.323 · 1.3230 (rough estimate)
refractive index
1.639 · 1.6390 (estimate)
storage temp.
2 · 2-8°C
pka
3.2 · 3.2(at 25℃)
optical activity
47.72 · +47.720 (c 1.25, H2O)
Water Solubility
20 g/L · >20g/L(21 ºC)
FDA UNII
1 VC61HB · LVZ1VC61HB
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
317 · H317
Precautionary statements
261 · P261-P272-P280-P302+P352-P333+P313-P321-P363-P501
Hazard Codes
Xn
Risk Statements
42 · 42/43
Safety Statements
22 · 22-36/37-45
Hazardous Substances Data
50 · 50-59-9(Hazardous Substances Data)
Toxicity
50 mice, · LD50 mice, rats (g/kg): >15, 2.5-4 orally; in monkeys (g/kg): >0.2 i.m. (Atkinson)

Toxicology

Interactions · 5 items

NON-IONIC, ANIONIC, & ZWITTERIONIC SURFACTANTS INDUCED RAPIDLY REVERSIBLE HYPER-ABSORPTIVE STATE IN THOMAS CANINE FUNDIC POUCH FOR CEPHALORIDINE...BLOOD LEVELS...MANY TIMES GREATER THAN VALUES IN CONTROLS.

CEPHALORIDINE SEEMS TO HAVE GREATEST POTENTIAL FOR NEPHROTOXICITY.../IT SHOULD NOT/ BE USED WITH GENTAMICIN /OR OTHER AMINOGLYCOSIDES, AMIKACIN, NEOMYCIN, PAROMOMYCIN & TOBRAMYCIN/ UNLESS LIFE-THREATENING CONDITION EXISTS /MAY INCR NEPHROTOXICITY/.

CEPHALORIDINE NEPHROTOXICITY IS ENHANCED BY CONCURRENT FUROSEMIDE ADMIN. SUCH THERAPY SHOULD BE AVOIDED IN PATIENTS WHO HAVE EVEN MILD PREEXISTING RENAL DISEASE.

...CEPHALOSPORINS...MAY BE AFFECTED BY CONCURRENT USE OF PROBENECID OR SULFINPYRAZONE. DIMINISHED TUBULAR SECRETION OF...WEAK ACIDS COULD RESULT IN HIGHER & MORE SUSTAINED SERUM LEVELS & HENCE, INTENSIFICATION OF DRUG ACTIVITY. /CEPHALOSPORINS/

Groups of ten male rats were treated with a high challenge dose of cephaloridine (3750 mg/kg), with methylprednisolone (100 mg/kg) or with cephaloridine and methylprednisolone by single sc injection. A control group received the injection vehicles only. Urine was collected from all animals daily over 18-hr collection periods, up to 96 hr after treatment. Blood was collected at 24, 48, 72 and 96 hr after treatment. At necropsy, kidneys were weighed, processed and examined histopathologically. Results show that methylprednisolone significantly ameliorated the nephrotoxicity of the challenge dose of cephaloridine. Cephaloridine-only treated rats had severe toxic nephrosis characterized by acute tubular necrosis, and elevated blood urea and creatinine. by contrast, the majority of cephaloridine plus methylprednisolone treated rats had only a slight or moderate toxic nephrosis, and had lower blood urea and creatinine levels compared with rats treated with cephaloridine only, indicating preservation of kidney function. Interestingly, rats treated with cephaloridine and methylprednisolone had higher urinary enzymes ... as well as protein and glucose, compared with rats treated with cephaloridine only. this is taken to indicate that rats treated with cephaloridine only had such marked kidney damage and necrosis that the population of cells able to produce these marker enzymes was significantly and rapidly depleted, but the protection afforded by methylprednisolone allowed cephaloridine plus methylprednisolone treated rats to sustain urinary enzyme output. Effects on urinary glucose and other parameters ... demonstrate interactions between glucocorticoid pharmacology and cephaloridine nephrotoxicity.

Human Toxicity Excerpts · 5 items

...CASE HAS BEEN REPORTED IN WHICH TREATMENT WITH THIS DRUG /CEPHALORIDINE/ IN EXTREMELY ILL 18-YR-OLD GIRL WITH STAPHYLOCOCCUS SEPTICEMIA WAS ASSOCIATED WITH ACUTE RENAL FAILURE & BLINDNESS, WITH MUCH PAPILLEDEMA & PIGMENTATION IN PERIPHERY OF FUNDI. RETINAL VESSELS WERE SAID TO BE NORMAL.

CEPHALORIDINE OCCASIONALLY CAUSES ALLERGY, MANIFESTED BY PRURITUS, URTICARIA, VARIOUS SKIN RASHES, FEVER, EOSINOPHILIA, OR ANAPHYLAXIS. ...MAY CAUSE NAUSEA & VOMITING. ... NEUROTOXICITY, SUCH AS TWITCHING, MYOCLONUS, & COMA, ALSO OCCURS WITH LARGE DOSES.

CEPHALORIDINE IS NEPHROTOXIC. RENAL INJURY DUE TO THIS DRUG OCCURS MOST OFTEN WITH ADMIN OF 6 G OR MORE/DAY. CLINICAL PICTURE THAT DEVELOPS HAS ALL FEATURES OF ACUTE TUBULAR NECROSIS. MECHANISM OF THIS REACTION IS UNKNOWN.

LARGE DOSES OF CEPHALORIDINE RESULT IN HIGH INCIDENCE OF GRANULAR CASTS IN URINE.

For more Human Toxicity Excerpts (Complete) data for CEPHALORIDINE (10 total), please visit the HSDB record page.

Non-Human Toxicity Excerpts · 5 items

NEPHROTOXIC. MAY PRODUCE FALSE POSITIVE GLUCOSE & COOMB'S TESTS.

RENAL TUBULAR NECROSIS FOLLOWING IM INJECTIONS OF CEPHALOTHIN INTO RATS. LESIONS WERE CONSISTENTLY PRODUCED WITH 5.0 G/KG & WERE MAXIMAL IN SEVERITY @ 2ND & 3RD DAYS FOLLOWING INJECTION.

... Effects on the ERG of rabbit retina in vitro were found, and in tests in rabbits it was shown that, while intravitreal injections of 0.25 mg or less caused no damage, 5 mg produced small retinal hemorrhages, and 10 mg caused clumping of the outer segments of the photoreceptors, destruction of retinal pigment epithelium, and extinction of the electroretinogram. Intravitreal injection of 25 mg caused complete destruction of the outer segments of photoreceptors and phagocytosis by cells from the retinal pigment epithelium; these changes proved irreversible.

... No retinotoxic effect was detected when this substance was injected intravenously, subconjunctivally or into the anterior chamber in rabbits in very large doses.

For more Non-Human Toxicity Excerpts (Complete) data for CEPHALORIDINE (8 total), please visit the HSDB record page.

Antidote and Emergency Treatment · 2 items

ADMIN OF PROBENECID CAN AMELIORATE NEPHROTOXICITY OF CEPHALORIDINE.

PERITONEAL DIALYSIS OR HEMODIALYSIS SIGNIFICANTLY REDUCES PLASMA CONCN OF /CEPHALORIDINE/...

Non-Human Toxicity Values · 2 items

LD50 MOUSE ORAL GREATER THAN 15 G/KG

LD50 MONKEY INTRAMUSCULAR GREATER THAN 0.2 G/KG

Regulatory information

FDA Requirements · 1 item

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Safety data

Toxicity
LD50 mice, rats (g/kg): >15, 2.5-4 orally; in monkeys (g/kg): >0.2 i.m. (Atkinson)
risk_code
42/43
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
22-36/37-45
Hazard statements
H317
Precautionary statements
P261-P272-P280-P302+P352-P333+P313-P321-P363-P501
Hazardous Substances Data
50-59-9(Hazardous Substances Data)

...CEPHALORIDINE...SHOWN...TO PENETRATE INTO BONE TO VERY LIMITED EXTENT AFTER SC OR ORAL DOSES TO RATS. RATIOS OF BONE TO SERUM CONCN AVG...1:7 FOR CEPHALORIDINE...DURING 0.25-4 HR AFTER DOSING.

Uses & manufacturing

Uses · 2 items

MEDICATION

MEDICATION (VET)

U.S. Production · 2 items

(1977) PROBABLY GREATER THAN 4.54X10+5 GRAMS

(1979) PROBABLY GREATER THAN 4.54X10+5 GRAMS

Consumption PatternsESSENTIALLY 100% AS AN ANTIBIOTIC
Methods of Manufacturing · 3 items

REACTION OF 7-AMINOCEPHALOSPORANIC ACID WITH THIOPHENE ACETYL CHLORIDE IN ACETONE TO FORM CEPHALOTHIN, THEN HEATING WITH A THIOCYANATE, PYRIDINE, AND PHOSPHORIC ACID, FOLLOWED BY PH ADJUSTMENT WITH A MINERAL ACID

AQ MIXT OF CEPHALOTHIN, THIOCYANATE, PYRIDINE, & PHOSPHORIC ACID IS HEATED FOR SEVERAL HR. ON COOLING, DILUTING WITH WATER, & ADJUSTING PH WITH MINERAL ACID, CEPHALORIDINE THIOCYANATE SALT PRECIPITATES WHICH IS PURIFIED & CONVERTED TO CEPHALORIDINE BY PH ADJUSTMENT OR BY INTERACTION WITH ION-EXCHANGE RESIN.

Cefalotin + pyridine (deacetylation)

General Manufacturing Information · 3 items

CEPHALOSPORINS ARE INCOMPATIBLE WITH ERYTHROMYCIN & TETRACYCLINES IN PARENTERAL MIXTURES. /CEPHALOSPORINS, FROM TABLE/

Because of its renal toxicity and the development of newer and more active synthetic cephalosporins, cephaloridine's use is declining.

This agent in no longer available in the US.

Applications · 3 items

DescriptionThis was derived by adding two side chains to the nucleus of cephalothin, and has the formula 7-(2-thienyl acetamido)-3-(1-pyridylmethyl)-3-cephem-4-carboxylic acid betaine (Muggleton et al., 1964). Cephaloridine was initially widely used, but it had two main disadvantages. It was an unreliable antistaphylococcal drug, as it was relatively easily hydrolyzed by Staphylococcus aureus beta-lactamase (Laverdiere et al., 1978; Sabath, 1989). Second, cephaloridine was nephrotoxic (Foord, 1975; Appel and Neu, 1977). Marketing of the drug was discontinued in the USA in December 1980. Nowadays, this drug is used very rarely, if at all.

UsesAntibacterial agent.

General DescriptionCephaloridine, along with cephalothin, was the first member of the synthetic cephalosporin C class of antibiotic, to be introduced clinically. It was synthesized, starting with 7-aminocephalosporanic acid, by Glaxo Research Laboratories in 1962. This drug shows strong activity against gram-positive and gramnegative bacteria and Leptospira, including benzylpenicillin-resistant strains. It has been given widely by intravenous, intramuscular, and intraspinal injection to treat a variety of infections caused by Staphylococcus, Streptococcus, Neisseria, Klebsiella, Escherichia coli, and other pathogens. Because of its renal toxicity and the development of newer and more active synthetic cephalosporins, its use is declining.

Upstream & downstream products

Upstream raw materials

Pyridine7-Aminocephalosporanic acid2-Thiopheneacetyl chloride2-Thiopheneacetic acid

Downstream products

4-EpoxypropanoxycarbazolePropylamine

Suppliers13 total

北京华美互利生物化工010-56205725 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
TargetMol 中国(陶术生物)400-821-0310 15002144251 · [email protected]
上海遐瑞医药科技有限公司+86 21 61551611
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
南通全益生物科技有限公司0513-66337626 18051384581 · [email protected]
成都标样生物科技有限公司028-81700200 13308200041 · [email protected]
杭州洁汉化工有限公司+86-571-86217390; +8618058761490 · [email protected]
合肥博美生物科技有限责任公司13739298932 13856598764 · [email protected]
陕西缔都医药化工有限公司029-029-029-81148696 18161915376 · [email protected]
Hefei TNJ Chemical Industry Co.,Ltd.+86-0551-65418671 +86-189 4982 3763 · [email protected]
AFINE CHEMICALS LIMITED+86-571-85134551 +86-18958018566 · [email protected]

Additional notes

DefinitionChEBI: A cephalosporin compound having pyridinium-1-ylmethyl and 2-thienylacetamido side-groups. A first-generation semisynthetic derivative of cephalosporin C.